Overview

Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of voclosporin in patients with plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Aurinia Pharmaceuticals Inc.
Treatments:
Cyclosporine
Cyclosporins